GeoVax raises ~$2.5M in registered direct offering; issues shares and warrants at $0.63

GeoVax Labs, Inc.

3,968,256 shares sold at $0.63 each with warrants to buy 11,904,768 shares at $0.63.
Gross proceeds ~$2.5M, net ~$2.325M after 7% placement agent fees.
Warrants exercisable only upon shareholder approval; expire 5 years from approval.
Roth Capital Partners acted as sole placement agent for the offering.
Proceeds to advance immunotherapies and vaccines pipeline including R&D and clinical studies.

item 1.01 item 3.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

GeoVax Labs, Inc. issued 11,904,768 shares of Common Stock of warrant.

Security: warrant
Shares: 11,904,768 shares of Common Stock

Exact text from the filing

In a concurrent private placement, the Company offered common warrants to the purchasers, with each warrant exercisable to purchase one share of Common Stock (the “Common Warrants”), with three Common Warrant to accompany each share of Common Stock sold in the Offering, and to purchase in the aggregate of 11,904,768 shares of Common Stock (the “Common Warrant Shares”).

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

GeoVax Labs, Inc. issued 3,968,256 shares of common stock for $0.63 per Share.

Security: common stock
Shares: 3,968,256 shares
Consideration: $0.63 per Share

Exact text from the filing

share of Common Stock sold in the Offering, and to purchase in the aggregate of 11,904,768 shares of Common Stock (the “Common Warrant Shares”). The public offering price was $0.63 for each Share coupled with the Common Warrants. The Common Warrants have an exercise price of $0.63 per share. Under the terms of the Purchase Agreement and to comply with Nasdaq

View on SEC.gov

Browse all equity issuances →

GeoVax Labs, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-25-030125

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.